Jakob Michaelis, Max Träger, Sophie Astheimer, Moritz von Büren, Elfi Gabele, Markus Grabbert, Jan Halbich, Marius Kamps, Jonas Klockenbusch, Theresa Noll, Phillippe Pohlmann, Daniel Schlager, August Sigle, Martin Schönthaler, Konrad Wilhelm, Christian Gratzke, Arkadiusz Miernik, Dominik Stefan Schöb
PURPOSE: The question of best surgical treatment for lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH) remains controversial. We compared the outcomes of aquablation and holmium laser enucleation of the prostate ("HoLEP") in a prospective cohort. METHODS: Patients with BPH underwent aquablation or HoLEP according to their preference between June 2020 and April 2022. Prostate volume ("PV"), laboratory results, postvoid residual volume, uroflowmetry, IPSS, ICIQ-SF, MSHQ-EjD, EES and IIEF were evaluated preoperatively and at three, six and 12 months postoperatively...
May 9, 2024: World Journal of Urology